The Primary Benefits Of Closed-System Manufacturing

Closed automated systems improve the reliability of cell therapy production by enhancing contamination control, consistency, operational efficiency, process control, scalability, and regulatory compliance. These advancements collectively contribute to producing high-quality, safe, and effective cell therapy products. Here, experts Will Junker and Nick Siciliano explain the primary benefits of closed-system manufacturing for cell therapies, particularly in terms of product quality, safety, and regulatory compliance.